Dextromethorphan, phenylephrine, and pyrilamine and Ibritumomab Intravenous
Determining the interaction of Dextromethorphan, phenylephrine, and pyrilamine and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dextromethorphan / phenylephrine / pyrilamine
Brand name: Codal-DM Syrup, Codimal DM, Codituss DM, Poly Hist DM, Viravan-DM, V-Tan DM, Zotex-12, Deconsal DM Tannate, Aldex DM, Viratan-DM, Triplex DM, MyHist-DM, Tannate V DM, Reme Hist DM, Pryil DM, Pyril DM
Synonyms: Pyril Mal Phenyl HCl Dex HBr
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextromethorphan, phenylephrine, and pyrilamine-Ibritumomab Tiuxetan
- Dextromethorphan, phenylephrine, and pyrilamine-Ibrutinib
- Dextromethorphan, phenylephrine, and pyrilamine-Ibrutinib Capsules
- Dextromethorphan, phenylephrine, and pyrilamine-Ibrutinib Tablets
- Dextromethorphan, phenylephrine, and pyrilamine-Ibu
- Dextromethorphan, phenylephrine, and pyrilamine-IBU Tablets
- Ibritumomab Intravenous-Dextrose
- Ibritumomab Intravenous-Dextrose 5% in Water
- Ibritumomab Intravenous-Dextrose 50% Injection
- Ibritumomab Intravenous-Dextrose and Electrolyte No 48
- Ibritumomab Intravenous-Dextrose Chewable Tablets
- Ibritumomab Intravenous-Dextrose Electrolyte No. 75